The finding arose from long-term follow-up of patients who received human growth hormone that was taken from brain tissue of deceased donors, but the risk is very low – and you can’t “catch” it like a virus.
A recent study from Sweden found people with a history of chronic stress or depression had a heightened risk of developing Alzheimer’s disease.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
Research into brain ageing may unlock the potential for the burgeoning science to be used in a clinical setting, providing a marker for cognitive health.
Up to 60% of people with dementia will get lost at some point after diagnosis – but are more likely to survive than other older people.
The symptoms of menopause, which can include sleep disturbance, depression, anxiety and “brain fog”, can span perimenopause and last for up to 10 years.
Beyond COVID-19, is AI part of the response to the failures of aged care?
The death of a family member inspired a rethinking of palliative care to make it more of a home away from home.
There's far more to the way we walk than we first thought, including it being a possible early indicator of dementia.
Sixty-three per cent of Australian aged care residents take at least nine different medications regularly.
There's a fundamental shift occurring in consumer behaviour, from conspicuous consumption to conscious consumption.
Regulating physical restraint of the elderly in nursing homes is a step in the right direction, but more still needs to be done to educate the sector on alternatives.
A power imbalance is leading to many patients negotiating with doctors and medical staff as if they are being held hostage.
Dummy text
